HRT Financial’s Health Catalyst HCAT Stock Holding History

HRT Financial’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	572,215 +329,024	+135%	+$475K	﹤0.01%	2090
2026 Q1	$308K	Buy	243,191 +230,553	+1,824%	+$434K	﹤0.01%	2855
2025 Q4	$30K	Buy	12,638 +968	+8%	+$2.65K	﹤0.01%	2942
2025 Q3	$33K	Buy	+11,670	New	+$39.9K	﹤0.01%	2647
2025 Q2	–	Sell	-13,865	Closed	-$62K	–	2996
2025 Q1	$62K	Buy	+13,865	New	+$73.4K	﹤0.01%	2217
2024 Q4	–	Sell	-10,026	Closed	-$81K	–	2718
2024 Q3	$81K	Buy	+10,026	New	+$72.4K	﹤0.01%	2066
2024 Q2	–	Sell	-111,842	Closed	-$842K	–	2553
2024 Q1	$842K	Sell	111,842 -79,241	-41%	-$723K	0.01%	967
2023 Q4	$1.77M	Buy	+191,083	New	+$1.56M	0.01%	708
2022 Q2	–	Sell	-25,968	Closed	-$678K	–	3233
2022 Q1	$678K	Buy	+25,968	New	+$737K	﹤0.01%	1412

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's HCAT Position: Q2 2026 in Review

HRT Financial increased its Health Catalyst (HCAT) stake by 135% in Q2 2026, buying an estimated $475K and bringing the position to 572,215 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2090.

HRT Financial first reported a position in HCAT in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.77M in Q4 2023. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

HRT Financial held 572,215 shares of Health Catalyst worth $1.14M as of Q2 2026.
HRT Financial bought 329,024 Health Catalyst shares in Q2 2026, an estimated $475K.
Health Catalyst made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2090 holding.
HRT Financial first reported a position in Health Catalyst in Q1 2022 and has held it in 9 quarters since.
HRT Financial's Health Catalyst position peaked at $1.77M in Q4 2023.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.